Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Clinical Laboratory|October 9, 2014
Omalizumab (anti-IgE) therapy increases blood glucose levels in severe persistent allergic asthma patients with diabetes mellitus: 18 month follow-upArzu Didem Yalcin, Reginald M Gorczynski, Aykut Cilli, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|March 18, 2015
Proteomics pattern of peritoneal sApo-2L but not CD200 (OX-2) as a possible screening biomarker for metastatic ovarian, endometrial and breast carcinomaBetul Celik, Arzu Didem Yalcin, Gizem Esra Genc, et al.
Immunopharmacology and Immunotoxicology|July 12, 2013
Effects of omalizumab on eosinophil cationic peptide, 25-hydroxyvitamin-D, IL-1β and sCD200 in cases of Samter's syndrome: 36 months follow-upArzu Didem Yalcin, Seçil Uçar, Saadet Gumuslu, et al.
Clinical Laboratory|April 5, 2014
Anti-IgE monoclonal antibody (omalizumab) is effective in treating bullous pemphigoid and its effects on soluble CD200Arzu Didem Yalcin, Gizem Esra Genc, Betul Celik, et al.
Clinical Laboratory|January 8, 2013
Interaction of allergic disease and (immune) response to cancer in patient with stage-4 adenocarcinoma of the lungArzu Didem Yalcin, Aysegul Kargi, Burhan Savas, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|July 3, 2014
Evaluation of d-dimer, CXCL8, homocysteine, eosinophil cationic peptide, 25(OH)-vitamin D and immunomodulatory OX-2 levels in allergic patientsSeda Tural Onur, Arzu Didem Yalcin, Betul Celik, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|September 29, 2012
Soluble trail as a marker of efficacy of allergen-specific immunotherapy in patients with allergic rhinoconjunctivitisArzu Didem Yalcin, Saadet Gumuslu, Gizem Esra Parlak, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|February 10, 2017
High serum soluble CD200 levels in patients with autosomal dominant polycystic kidney diseaseFunda Sari, Saadet Gumuslu, Ramazan Cetinkaya, et al.
Central-European Journal of Immunology|January 18, 2021
Human(ized) monoclonal antibodies in atopic patients - state of the artArzu Didem Yalcin, Kevser Onbasi, Rusen Uzun, et al.
The American Journal of Case Reports|September 17, 2016
Levofloxacin Induced Toxic Epidermal Necrolysis: Successful Therapy with Omalizumab (Anti-IgE) and Pulse PrednisoloneRusen Uzun, Arzu Didem Yalcin, Betul Celik, et al.
Pageof 5